Indoleamine 2,3-dioxygenase 1 (IDO1) suppressed the CD8+ T cell response in colon cancer, while miR-448, as a tumor-suppressive miRNA, enhanced the CD8+ T cell response by inhibiting IDO1 expression [45]. This evidence concerns the gene CD8A and colonic neoplasm.